Business
iFabric Corp. Announces Launch of Aura Scrubs at U.S. National Mass Retailer
Third major retailer to adopt IFTNA's technology-enhanced scrub platform New Brand Expands...
About this update from Ifabric Corp.
iFabric Corp. Announces Launch of Aura Scrubs at U.S. National Mass RetailerThird major retailer to adopt IFTNA's technology-enhanced scrub platformNew Brand Expands Commercial Reach of PROTX2® and ecoPEL™, the Company's Proprietary Antimicrobial and Durable Water Repellant Technologies MARKHAM, ON / ACCESS Newswire / July 13, 2026 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) is pleased to announce that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), is launching Aura, a new performance medical apparel scrubs line developed, branded, and manufactured by IFTNA, in cooperation with a leading U.S. national mass retailer.The Aura scrubs collection is launching in approximately 400 brick-and-mortar stores across the United States, together with availability on the retailer's well-established e-commerce platform. The Company believes the program has the potential for expansion across additional stores, subject to consumer adoption, retail performance, and ongoing retailer planning.Aura scrubs integrate two of IFTNA's flagship textile technologies: PROTX2®, IFTNA's advanced antimicrobial technology, and ecoPEL, IFTNA's fluorine-free durable water-repellent technology. Together, these technologies are designed to deliver enhanced performance for healthcare professionals working in demanding clinical environments."This launch marks another important milestone in our mission to make clinically supported textile technologies more readily accessible to healthcare professionals," said Giancarlo Beevis, President and CEO of IFTNA. "Aura brings together comfort, fit, function, and our class-leading PROTX2® and ecoPEL technologies in a product platform designed for everyday clinical use and delivered through one of the most important retail channels in the United States," added Mr. Beevis.An IFTNA-sponsored clinical trial demonstrated statistically-significant reductions in surface bacterial contamination on treated scrubs worn in real-world healthcare environments compared with untreated scrubs, as published in the peer-reviewed Journal of Hospital Infection and available online at:https://www.journalofhospitalinfection.com/article/S0195-6701(25)00222-1/fulltextBy integrating PROTX2® and ecoPEL into Aura scrubs, IFTNA is bringing the benefits of its clinically-validated textil...